These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28364163)

  • 21. Ten years of atomic medicine.
    WARREN S
    Mil Med; 1956 Apr; 118(4):257-9. PubMed ID: 13308832
    [No Abstract]   [Full Text] [Related]  

  • 22. Environmental levels of radioactivity at Atomic Energy Commission installations. 1. Knolls Atomic Power Laboratory-Windsor Site (SIC Prototype Reactor Facility) January-December 1971. 2. Portsmouth Area Gaseous Diffusion Plant, January-December 1971.
    Radiat Data Rep; 1974 Jan; 15(1):30-5. PubMed ID: 4818372
    [No Abstract]   [Full Text] [Related]  

  • 23. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?
    Guerard F; Barbet J; Chatal JF; Kraeber-Bodere F; Cherel M; Haddad F
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):161-7. PubMed ID: 25752501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).
    Wild D; Frischknecht M; Zhang H; Morgenstern A; Bruchertseifer F; Boisclair J; Provencher-Bolliger A; Reubi JC; Maecke HR
    Cancer Res; 2011 Feb; 71(3):1009-18. PubMed ID: 21245097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Values of "S," , and <(z1)2> for dosimetry using alpha-particle emitters.
    Stinchcomb TG; Roeske JC
    Med Phys; 1999 Sep; 26(9):1960-71. PubMed ID: 10505886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted α therapy for cancer: where we are today and where we are heading.
    Melville G
    Future Oncol; 2015 Nov; 11(22):3065-7. PubMed ID: 26436906
    [No Abstract]   [Full Text] [Related]  

  • 28. Heavy particle radiations--some therapeutic considerations.
    Hazel JJ; Lawrence JH; Tobias CA
    J Can Assoc Radiol; 1966 Sep; 17(3):158-61. PubMed ID: 4959641
    [No Abstract]   [Full Text] [Related]  

  • 29. Preventive medicine in the atomic energy industry.
    Evans DW; Stewart CG; Marko AN
    Environ Health Ser Radiol Health; 1968 Sep; 33():87-96. PubMed ID: 5731968
    [No Abstract]   [Full Text] [Related]  

  • 30. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor therapy with targeted atomic nanogenerators.
    McDevitt MR; Ma D; Lai LT; Simon J; Borchardt P; Frank RK; Wu K; Pellegrini V; Curcio MJ; Miederer M; Bander NH; Scheinberg DA
    Science; 2001 Nov; 294(5546):1537-40. PubMed ID: 11711678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-particles for targeted therapy.
    Sgouros G
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1402-6. PubMed ID: 18541332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status and perspectives in alpha radioimmunotherapy.
    Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population.
    Roeske JC; Stinchcomb TG
    Phys Med Biol; 2006 May; 51(9):N179-86. PubMed ID: 16625028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stopping power and range of alpha particles.
    Walsh PJ
    Health Phys; 1970 Aug; 19(2):312-6. PubMed ID: 5513488
    [No Abstract]   [Full Text] [Related]  

  • 37. Energy-range relation and mean energy variation in therapeutic particle beams.
    Kempe J; Brahme A
    Med Phys; 2008 Jan; 35(1):159-70. PubMed ID: 18293572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental levels of radioactivity at Atomic Energy Commission installations.
    Radiol Health Data Rep; 1971 Apr; 12(4):228-33. PubMed ID: 5109522
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the demonstration of alpha-ray energy deposition in smallest bands].
    Rimpl GR
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:135-6. PubMed ID: 4344528
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cancer and radiotherapy. (7) Radiation therapy with proton, alpha particles, heavy ions and negative pion beams].
    Akanuma A
    Iyodenshi To Seitai Kogaku; 1983 Apr; 21(2):128-34. PubMed ID: 6317923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.